MAS clinical trials at UCLA

1 in progress, 0 open to eligible people

PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE
Sorry, in progress, not accepting new patients
The purpose of this study is to assess the safety, tolerability and efficacy of emapalumab in children and adults with macrophage activation syndrome (sHLH/MAS) in Still's disease (including systemic juvenile idiopathic arthritis and adult onset Still's disease) or with sHLH/MAS in systemic lupus erythematous, resenting an inadequate response to high dose glucocorticoid treatment.
Los Angeles, California and other locations

Last updated: October 14, 2024

PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE